These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24786790)

  • 1. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.
    Luo ML; Gong C; Chen CH; Lee DY; Hu H; Huang P; Yao Y; Guo W; Reinhardt F; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP
    Cancer Res; 2014 Jul; 74(13):3603-16. PubMed ID: 24786790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation.
    Luo ML; Gong C; Chen CH; Hu H; Huang P; Zheng M; Yao Y; Wei S; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP
    Cell Rep; 2015 Apr; 11(1):111-24. PubMed ID: 25818297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.
    Rustighi A; Zannini A; Tiberi L; Sommaggio R; Piazza S; Sorrentino G; Nuzzo S; Tuscano A; Eterno V; Benvenuti F; Santarpia L; Aifantis I; Rosato A; Bicciato S; Zambelli A; Del Sal G
    EMBO Mol Med; 2014 Jan; 6(1):99-119. PubMed ID: 24357640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
    Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
    Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.
    Wulf G; Garg P; Liou YC; Iglehart D; Lu KP
    EMBO J; 2004 Aug; 23(16):3397-407. PubMed ID: 15257284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis.
    Tan X; Zhou F; Wan J; Hang J; Chen Z; Li B; Zhang C; Shao K; Jiang P; Shi S; Feng X; Lv N; Wang Z; Ling Y; Zhao X; Ding D; Sun J; Xiong M; He J
    Cancer Biol Ther; 2010 Jan; 9(2):111-9. PubMed ID: 20009523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolyl isomerase Pin1 in breast development and cancer.
    Wulf G; Ryo A; Liou YC; Lu KP
    Breast Cancer Res; 2003; 5(2):76-82. PubMed ID: 12631385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells.
    Jin J; Zhang Y; Li Y; Zhang H; Li H; Yuan X; Li X; Zhou W; Xu B; Zhang C; Zhang Z; Zhu L; Chen X
    Neoplasma; 2013; 60(1):92-100. PubMed ID: 23067222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shrimp miRNA suppresses the stemness of human cancer stem cells
    Zhang S; Zhang X
    FASEB J; 2019 Oct; 33(10):10767-10779. PubMed ID: 31284761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression.
    Yun HJ; Kim JY; Kim G; Choi HS
    Anticancer Res; 2014 Mar; 34(3):1409-16. PubMed ID: 24596388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells.
    Ryo A; Liou YC; Wulf G; Nakamura M; Lee SW; Lu KP
    Mol Cell Biol; 2002 Aug; 22(15):5281-95. PubMed ID: 12101225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression.
    Choi HJ; Kim JY; Lim SC; Kim G; Yun HJ; Choi HS
    Br J Pharmacol; 2015 Nov; 172(21):5096-109. PubMed ID: 26267432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
    Suizu F; Ryo A; Wulf G; Lim J; Lu KP
    Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.
    Wei S; Kozono S; Kats L; Nechama M; Li W; Guarnerio J; Luo M; You MH; Yao Y; Kondo A; Hu H; Bozkurt G; Moerke NJ; Cao S; Reschke M; Chen CH; Rego EM; Lo-Coco F; Cantley LC; Lee TH; Wu H; Zhang Y; Pandolfi PP; Zhou XZ; Lu KP
    Nat Med; 2015 May; 21(5):457-66. PubMed ID: 25849135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.
    Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L
    Tumori; 2016; 102(2):144-9. PubMed ID: 26917410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.
    Yan X; Zhu Z; Xu S; Yang LN; Liao XH; Zheng M; Yang D; Wang J; Chen D; Wang L; Liu X; Liu J; Chen RH; Zhou XZ; Lu KP; Liu H
    Sci Rep; 2017 Apr; 7():45915. PubMed ID: 28383568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
    Ryo A; Uemura H; Ishiguro H; Saitoh T; Yamaguchi A; Perrem K; Kubota Y; Lu KP; Aoki I
    Clin Cancer Res; 2005 Oct; 11(20):7523-31. PubMed ID: 16243827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.